ConductScience.org, home

Paper23680930

Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study.

Orozco L and 8 others. Transplantation, 2013. Cited by 337 papers, by iCite.

Cite this record

ConductScience Library. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Papers, record 23680930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23680930

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study.
PubMed
Journal
Transplantation
PubMed
Year
2013
PubMed
Publication types
Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
337
iCite
Relative citation ratio, by iCite
13.3
iCite
Revised in PubMed
2022-04-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Orozco LLluis
2Munar AAnna
3Soler RRobert
4Alberca MMercedes
5Soler FFrancesc
6Huguet MMarina
7Sentís JJoan
8Sánchez AAna
9García-Sancho JJavier

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mesenchymal Stem CellsMajor topic
Osteoarthritis, KneeMajor topic
Adult
Bone Marrow Cells
Cartilage
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Pain Measurement
Pilot Projects
Quality of Life
Treatment Outcome

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01183728Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem CellsResultsClinicalTrials.gov
NCT01586312Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem CellsBackgroundClinicalTrials.gov
NCT05660824
Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study.
BackgroundClinicalTrials.gov

Download CSV of trials

Cited by211

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 337 citations.

PMIDTitleJournalYearIn PapersSource
42668582Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities.J Transl Autoimmun2026https://conductscience.org/library/papers/42668582PubMed
42626470Cord blood mesenchymal stromal cells combined with hyaluronic acid show symptom-modifying and potential disease-modifying effects in an equine osteoarthritis fetlock chip model.Front Vet Sci2026https://conductscience.org/library/papers/42626470PubMed
42077270Current and emerging therapies for knee osteoarthritis: From conventional approaches to machine learning and stem cell innovations.Regen Ther2026https://conductscience.org/library/papers/42077270PubMed
42006954Preclinical and early clinical safety of intra-articular spheroid adipose-derived stem cells for knee osteoarthritis: A translational study.Osteoarthr Cartil Open2026https://conductscience.org/library/papers/42006954PubMed
41836180Influence of Synovial Fluid Biochemical Markers on Clinical Outcomes Following Arthroscopic and Non-Arthroscopic Patients with Knee Osteoarthritis.Orthop Rev (Pavia)2026https://conductscience.org/library/papers/41836180PubMed
41598166Cell Surface Markers of Mesenchymal Stem Cells: Current Knowledge and Advances in Characterization Technologies.Life (Basel)2025https://conductscience.org/library/papers/41598166PubMed
41301106Intra-Articular Injection of Bone Marrow Concentrate for Patellofemoral Osteoarthritis Treatment: Preliminary Results Using a New Tibial Endplate Sample Under Ultrasound Guidance.Bioengineering (Basel)2025https://conductscience.org/library/papers/41301106PubMed
41163019Intra-articular delivery of allogeneic bone marrow derived mesenchymal stromal cells (BM-MSCs) for painful lumbar facet arthropathy: a phase I clinical trial.Stem Cell Res Ther2025https://conductscience.org/library/papers/41163019PubMed
41104102Mechanism and application of injectable hydrogel as carrier system in the treatment of osteoarthritis.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/41104102PubMed
40951711Entering the era of living biopharmaceuticals for treating knee osteoarthritis: A systematic review and network meta-analysis.World J Stem Cells2025https://conductscience.org/library/papers/40951711PubMed
40943401
Cartilage Regeneration Potential in Early Osteoarthritis of the Knee: A Prospective, Randomized, Open, and Blinded Endpoint Study Comparing Adipose-Derived Mesenchymal Stem Cell (ADSC) Therapy Versus Hyaluronic Acid.
Int J Mol Sci2025https://conductscience.org/library/papers/40943401PubMed
40721701Advancing osteoarthritis management: integrating new insights and addressing persistent roadblocks.Inflammopharmacology2025https://conductscience.org/library/papers/40721701PubMed
40566402Effects of Injections of Monocytes, Platelet-Rich Plasma, and Hyaluronic Acid in Adults with Knee Osteoarthritis: An Observational Study.J Funct Morphol Kinesiol2025https://conductscience.org/library/papers/40566402PubMed
40565232Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions.Int J Mol Sci2025https://conductscience.org/library/papers/40565232PubMed
40565230Advances in Regenerative Therapies for Inflammatory Arthritis: Exploring the Potential of Mesenchymal Stem Cells and Extracellular Vesicles.Int J Mol Sci2025https://conductscience.org/library/papers/40565230PubMed
40169165Stem cell injections for osteoarthritis of the knee.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/40169165PubMed
40144957Efficacy of intra-articular injections for the treatment of osteoarthritis: A narrative review.Osteoarthr Cartil Open2025https://conductscience.org/library/papers/40144957PubMed
40002922A Narrative Review on Manufacturing Methods Employed in the Production of Mesenchymal Stromal Cells for Knee Osteoarthritis Therapy.Biomedicines2025https://conductscience.org/library/papers/40002922PubMed
39801757Mesenchymal stem cells for osteoarthritis: Recent advances in related cell therapy.Bioeng Transl Med2025https://conductscience.org/library/papers/39801757PubMed
39629035Efficacy and safety of mesenchymal stem cell injections for knee osteoarthritis: A systematic review and meta-analysis.J Res Med Sci2024https://conductscience.org/library/papers/39629035PubMed

See all 211 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23680930

GET https://conductscience.org/api/papers/v1/23680930/cited_by?page=2